TLR9-IL-2 axis exacerbates allergic asthma by preventing IL-17A hyperproduction

Area of Science:

• Immunology
• Allergy and Asthma Research
• Innate Immunity

Background:

• Allergic asthma involves lung inflammation, with host DNA implicated in pathology.
• The role of DNA-recognizing innate immune receptors, like Toll-Like Receptor 9 (TLR9), in asthma remains unclear.
• Investigating TLR9's function in house dust mite (HDM)-induced allergic asthma is crucial.

Purpose of the Study:

• To elucidate the role of Toll-Like Receptor 9 (TLR9) in the pathogenesis of allergic asthma.
• To assess the impact of TLR9 deficiency and blockade on asthma development and immune responses.
• To explore the potential of targeting TLR9 as a therapeutic strategy for allergic asthma.

Main Methods:

• Induction of allergic asthma using house dust mite (HDM) in wild-type and Tlr9-deficient (Tlr9^-/-) mice.
• Administration of a TLR9-inhibitory antibody (NaR9) to block TLR9 function.
• Analysis of airway hyperresponsiveness, eosinophil counts, and cytokine profiles (Th2, IL-17A, IL-2).

Main Results:

• Tlr9^-/- mice exhibited reduced airway hyperresponsiveness, eosinophilia, and suppressed Th2 cytokines (IL-13, IL-5, IL-4).
• IL-17A production was increased, and IL-2 production was decreased in Tlr9^-/- mice.
• TLR9 blockade with NaR9 effectively suppressed allergic asthma pathology and enhanced IL-17A production.

Conclusions:

• The TLR9-IL-2 axis plays a significant role in modulating IL-17A production within Th2 inflammation in HDM-induced allergic asthma.
• Targeting TLR9 presents a promising novel therapeutic approach for managing allergic asthma.
• Understanding TLR9's involvement offers new insights into innate immune receptor function in allergic airway disease.